Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Internet Oversight “Ripe For Comment” In Free Speech Analysis – Lawyer

This article was originally published in The Tan Sheet

Executive Summary

FDA's regulation of claims made over the Internet is one aspect of policymaking that remains "ripe for comment" as the agency seeks public feedback on its regulatory decisions in light of recent First Amendment case law, Morgan Lewis partner Sandra Dennis opined

You may also be interested in...



Structure/Function Claim Pre-Market Substantiation Urged By Former FDAer

A mandatory pre-market substantiation program for structure/function claims covering both foods and dietary supplements should be created by FDA, former deputy commissioner for policy Michael Taylor contends

Structure/Function Claim Pre-Market Substantiation Urged By Former FDAer

A mandatory pre-market substantiation program for structure/function claims covering both foods and dietary supplements should be created by FDA, former deputy commissioner for policy Michael Taylor contends

Structure/Function Claim Pre-Market Substantiation Urged By Former FDAer

A mandatory pre-market substantiation program for structure/function claims covering both foods and dietary supplements should be created by FDA, former deputy commissioner for policy Michael Taylor contends

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel